Literature DB >> 1454824

Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.

R Glas1, L Franksson, C Ohlén, P Höglund, B Koller, H G Ljunggren, K Kärre.   

Abstract

Cytotoxic T lymphocytes (CTLs) recognize major histocompatibility complex (MHC) class I molecules, normally composed of a heavy chain, a beta 2-microglobulin (beta 2m), and peptide antigens. beta 2m is considered essential for the assembly and intracellular transport of MHC class I molecules as well as their peptide presentation to CTLs. Contrary to this dogma, we now report the generation of allospecific and restricted CD8+ and TCR alpha beta+ CTLs (where TCR is T-cell receptor) capable of killing beta 2m-deficient cells. Such CTLs were obtained by priming mice with live allogeneic beta 2m- spleen cells or mutant lymphoma cells producing MHC class I protein but no detectable beta 2m. Although both beta 2m- and beta 2m-expressing lymphoma cells were rejected in allogeneic mice, only the former were efficient inducers of CTLs recognizing beta 2m- cells. These CTLs were MHC class I (H-2Kb or Db)-specific and CD8-dependent and did not require serum as a source of external beta 2m in the culture. They could be induced across major and minor histocompatibility barriers. The H-2-restricted CTLs generated in the latter case failed to kill the antigen-processing-deficient target RMA-S cells. The results show that MHC class I heavy chains in beta 2m- cells can be transported to the cell surface and act as antigens or antigen-presenting molecules to allospecific and MHC-restricted CTLs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454824      PMCID: PMC50554          DOI: 10.1073/pnas.89.23.11381

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Ham-2 corrects the class I antigen-processing defect in RMA-S cells.

Authors:  M Attaya; S Jameson; C K Martinez; E Hermel; C Aldrich; J Forman; K F Lindahl; M J Bevan; J J Monaco
Journal:  Nature       Date:  1992-02-13       Impact factor: 49.962

2.  Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Authors:  A Townsend; C Ohlén; J Bastin; H G Ljunggren; L Foster; K Kärre
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

3.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.

Authors:  M L Wei; P Cresswell
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

4.  Defective presentation of endogenous antigen by a cell line expressing class I molecules.

Authors:  N A Hosken; M J Bevan
Journal:  Science       Date:  1990-04-20       Impact factor: 47.728

5.  The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains.

Authors:  J Alexander; J A Payne; B Shigekawa; J A Frelinger; P Cresswell
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Differential transport requirements of HLA and H-2 class I glycoproteins.

Authors:  J Alexander; J A Payne; R Murray; J A Frelinger; P Cresswell
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin.

Authors:  B Arce-Gomez; E A Jones; C J Barnstable; E Solomon; W F Bodmer
Journal:  Tissue Antigens       Date:  1978-02

Review 8.  MHC antigen expression in colorectal tumours.

Authors:  M E Smith
Journal:  Semin Cancer Biol       Date:  1991-02       Impact factor: 15.707

9.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

10.  RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes.

Authors:  F Esquivel; J Yewdell; J Bennink
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  20 in total

1.  Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.

Authors:  E Z Wolpert; M Petersson; B J Chambers; J K Sandberg; R Kiessling; H G Ljunggren; K Kärre
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.

Authors:  D G Quinn; A J Zajac; C E Hioe; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 3.  Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges.

Authors:  Julie B Sneddon; Qizhi Tang; Peter Stock; Jeffrey A Bluestone; Shuvo Roy; Tejal Desai; Matthias Hebrok
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

4.  Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells.

Authors:  Y Vugmeyster; R Glas; B Pérarnau; F A Lemonnier; H Eisen; H Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL.

Authors:  Yongzhi Cui; Masahiro Onozawa; Haven R Garber; Leigh Samsel; Ziyao Wang; J Philip McCoy; Sandra Burkett; Xiaolin Wu; Peter D Aplan; Crystal L Mackall
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

6.  CD8+ T cells are essential for controlling acute friend retrovirus infection in C57BL/6 mice.

Authors:  Jara J Joedicke; Gennadiy Zelinskyy; Ulf Dittmer; Kim J Hasenkrug
Journal:  J Virol       Date:  2014-05       Impact factor: 5.103

Review 7.  Conformational changes induced in the MHC class I molecule by peptide and beta 2-microglobulin.

Authors:  J C Solheim; J R Cook; T H Hansen
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

8.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

9.  The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Authors:  A Henke; S Huber; A Stelzner; J L Whitton
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  A mutation in the alpha 3 domain of Db that abrogates CD8 binding does not affect presentation of an immunodominant H-Y peptide.

Authors:  J P Dutz; S J Teh; N Killeen; H S Teh
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.